Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Owen CN"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Richenberg G; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Francis A; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Owen CN; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Bristol Cancer Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Gray V; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Robinson T; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Bristol Cancer Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Gabriel AA; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Lawrenson K; Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Crosbie EJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Department of Obstetrics and Gynaecology, Manchester University NHS Foundation Trust, St. Mary's Hospital, Manchester, UK., Schildkraut JM; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Mckay JD; Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France., Gaunt TR; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Relton CL; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Vincent EE; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Kar SP; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Early Cancer Institute, University of Cambridge, Cambridge, UK.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2023 Oct 10. Date of Electronic Publication: 2023 Oct 10.
Autor:
Attrill GH; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Owen CN; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; The University of Bristol, Bristol Cancer Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Ahmed T; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Vergara IA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Oncology and Diagnostic Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Conway JW; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Nahar KJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital; Mater Hospital, Sydney, New South Wales, Australia., Pires da Silva I; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Lo S; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Palendira U; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Oncology and Diagnostic Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia james.wilmott@sydney.edu.au.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jun; Vol. 10 (6).
Autor:
Owen CN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Bai X; Massachusetts General Hospital, Boston, USA; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma, Peking University Cancer Hospital & Institute, Beijing, China., Quah T; Westmead and Blacktown Hospitals, Sydney, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Allayous C; Dermatology Department, Université de Paris, AP-HP Saint-Louis Hospital, INSERM, Paris, France., Callaghan S; The Christie NHS Foundation Trust, Manchester, UK., Martínez-Vila C; Hospital Clinic Barcelona, Barcelona, Spain., Wallace R; Peter MacCallum Cancer Centre and the University of Melbourne, Melbourne, Australia., Bhave P; The Alfred Hospital, Melbourne, Australia., Reijers ILM; Netherlands Cancer Institute, Amsterdam, The Netherlands., Thompson N; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Vanella V; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Gerard CL; Lausanne University Hospital, Lausanne, Switzerland., Aspeslagh S; University Hospital Brussels, Brussels, Belgium., Labianca A; Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy., Khattak A; Fiona Stanley Hospital and Edith Cowan University, Perth, Australia., Mandala M; University of Perugia, Unit of Medical Oncology, Santa Maria misericordia hospital, Perugia, Italy., Xu W; Princess Alexandra Hospital and The University of Queensland, Brisbane, Australia., Neyns B; University Hospital Brussels, Brussels, Belgium., Michielin O; Lausanne University Hospital, Lausanne, Switzerland., Blank CU; Netherlands Cancer Institute, Amsterdam, The Netherlands., Welsh SJ; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Haydon A; The Alfred Hospital, Melbourne, Australia., Sandhu S; Peter MacCallum Cancer Centre and the University of Melbourne, Melbourne, Australia., Mangana J; Dermatology, Department of Dermato-Oncology, University Hospital Zurich, Zürich, Switzerland., McQuade JL; The University of Texas MD Anderson Cancer Center, Houston, USA., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Zimmer L; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Johnson DB; Vanderbilt University Medical Center, Nashville, USA., Arance A; Hospital Clinic Barcelona, Barcelona, Spain., Lorigan P; The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK., Lebbé C; Dermatology Department, Université de Paris, AP-HP Saint-Louis Hospital, INSERM, Paris, France., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Westmead and Blacktown Hospitals, Sydney, Australia., Sullivan RJ; Massachusetts General Hospital, Boston, USA., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia. Electronic address: georgina.long@sydney.edu.au., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Jul; Vol. 32 (7), pp. 917-925. Date of Electronic Publication: 2021 Mar 30.
Autor:
Knispel S; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Gassenmaier M; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia., Loquai C; Department of Dermatology, University Medical Center Mainz, Mainz, Germany., Johnson DB; Vanderbilt University Medical Center, Nashville, USA., Franklin C; Department of Dermatology and Venereology, Skin Cancer Center at the Center of Integrated Oncology (CIO) Köln Bonn, University Hospital of Cologne, Cologne, Germany., Gutzmer R; Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany., Hassel JC; Skin Cancer Center, Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany., Weishaupt C; Department of Dermatology, University Hospital of Muenster, Muenster, Germany., Eigentler T; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Schilling B; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany., Schummer P; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany., Sirokay J; Department of Dermatology, University Hospital Bonn, Bonn, Germany., Kiecker F; Department of Dermatology, University Hospital Charité Berlin, Berlin, Germany., Owen CN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Fleischer MI; Department of Dermatology, University Medical Center Mainz, Mainz, Germany., Cann C; Vanderbilt University Medical Center, Nashville, USA., Kähler KC; Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany., Mohr P; Department of Dermatology, Elbe-Klinikum Buxtehude, Buxtehude, Germany., Bluhm L; Department of Dermatology, Elbe-Klinikum Buxtehude, Buxtehude, Germany., Niebel D; Department of Dermatology, University Hospital Bonn, Bonn, Germany., Thoms KM; Department of Dermatology, University Medical Center Goettingen, Göttingen, Germany., Goldinger SM; Department of Dermatology, University Hospital Zürich, Zürich, Switzerland., Reinhardt L; Department of Dermatology, Skin Cancer Center at the National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany., Meier F; Department of Dermatology, Skin Cancer Center at the National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany., Berking C; Department of Dermatology, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen - Metropolitan Region of Nuremberg, Deutsches Zentrum Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany., Reinhard R; Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Mannheim, Germany., Susok L; Department of Dermatology, St. Josef-Hospital Bochum, Bochum, Germany., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Drexler K; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany., Pföhler C; Department of Dermatology, Saarland University Medical School, Homburg/Saar, Germany., Tietze J; Department of Dermatology, University Hospital Rostock, Rostock, Germany., Heinzerling L; Department of Dermatology, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen - Metropolitan Region of Nuremberg, Deutsches Zentrum Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany., Livingstone E; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Ugurel S; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia., Stang A; Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany., Schadendorf D; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Zimmer L; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany. Electronic address: lisa.zimmer@uk-essen.de.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 May; Vol. 148, pp. 61-75. Date of Electronic Publication: 2021 Mar 15.
Autor:
Owen CN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Shoushtari AN; Memorial Sloan Kettering Cancer Center, New York, USA., Chauhan D; The Royal Marsden NHS Foundation Trust, London, UK., Palmieri DJ; Westmead Hospital and Blacktown Hospitals, Sydney, Australia., Lee B; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia., Rohaan MW; Netherlands Cancer Institute, Amsterdam, Netherlands., Mangana J; University Hospital Zurich, Zürich, Switzerland., Atkinson V; Greenslopes Private Hospital, Princess Alexandra Hospital and The University of Queensland, Brisbane, Australia., Zaman F; The Alfred Hospital, Melbourne, Australia., Young A; Vanderbilt University Medical Center, Nashville, USA., Hoeller C; Medical University of Vienna, Vienna, Austria., Hersey P; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Dummer R; University Hospital Zurich, Zürich, Switzerland., Khattak MA; Fiona Stanley Hospital, The University of Western Australia, Perth, Australia., Millward M; School of Medicine and Pharmacology, Nedlands, Australia., Patel SP; The University of Texas MD Anderson Cancer Center, Houston, USA., Haydon A; The Alfred Hospital, Melbourne, Australia., Johnson DB; Vanderbilt University Medical Center, Nashville, USA., Lo S; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Blank CU; Netherlands Cancer Institute, Amsterdam, Netherlands., Sandhu S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Westmead Hospital and Blacktown Hospitals, Sydney, Australia., Larkin JMG; The Royal Marsden NHS Foundation Trust, London, UK., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia. Electronic address: georgina.long@sydney.edu.au.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Aug; Vol. 31 (8), pp. 1075-1082. Date of Electronic Publication: 2020 May 06.